Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats

• Published in: Journal of endocrinology Vol. 229; no. 2; pp. 61 - 72
• Main Authors: Gaspar, Renato Simões, Benevides, Renata Ohana Alves, Fontelles, João Lucas de Lima, Vale, Caroline Castro, França, Lucas Martins, Barros, Paulo de Tarso Silva, Paes, Antonio Marcus de Andrade
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.05.2016
• Subjects: Androgens - metabolism; Animals; Animals, Newborn; Anti-Mullerian Hormone - metabolism; Disease Models, Animal; Female; Hyperinsulinism - chemically induced; Hyperinsulinism - physiopathology; Metabolic Networks and Pathways - drug effects; Metabolic Syndrome - chemically induced; Metabolic Syndrome - physiopathology; Obesity - chemically induced; Obesity - pathology; Obesity - physiopathology; Ovary - drug effects; Ovary - metabolism; Ovary - pathology; Polycystic Ovary Syndrome - chemically induced; Polycystic Ovary Syndrome - physiopathology; Rats; Rats, Wistar; Reproduction - drug effects; Sodium Glutamate - toxicity; metabolic syndrome; reproductive disorders; proliferation; monosodium l-glutamate; hypothalamic obesity
• ISSN: 0022-0795; 1479-6805
• DOI: 10.1530/JOE-15-0453

Obesity and metabolic syndrome are the common causes of reproductive and fertility disorders in women. In particular, polycystic ovary syndrome, which is clinically characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology, has been increasingly associated with metabolic disorders. However, given the broad interplay between metabolic and reproductive functions, this remains a field of intense research. In this study, we investigated the effect of monosodium l-glutamate (MSG)-induced obesity on reproductive biology of female rats. Newborn female rats were subcutaneously injected with MSG (4g/kg/day) or equiosmolar saline (CTR) each 2 days up to postnatal day (pnd) 10. On pnd 60, estrous cycle was evaluated using vaginal smears twice a day for 15 days, which showed MSG rats to be oligocyclic. Thereafter, animals were killed on estrous phase for blood and tissue collection. MSG rats had increased body mass, accumulation of retroperitoneal and visceral fat pads, and visceral adipocyte hypertrophy compared with CTR rats. MSG rats were also dyslipidemic and hyperinsulinemic but were normoglycemic and normoandrogenic. Ovarian morphology analysis showed that MSG rats had a two-fold decrease in oocyte count but a six-fold increase on ovarian follicular cysts, along with a higher number of total primordial and atretic follicles. Moreover, MSG rats had a four-fold increase in anti-Müllerian hormone immunohistochemical staining on antral follicles. Taken together, data presented here characterize MSG obesity as a unique model to study the metabolic pathways underlying reproductive disorders in the absence of overactivated hypothalamic–pituitary–gonadal axis.